| Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | May 31,
2021 | May 31,
2022 | May 31,
2023 | May 31,
2024 | May 31,
2025 |
|---|
| Net loss | - | - | - | -336 | -434 | -1,443 | -222 | -2,181 |
|---|
| Deferred income tax recovery | - | - | - | - | - | -32 | -39 | -121 |
|---|
| Unrealized foreign exchange (gain) loss | -6 | 6 | 13 | -49 | -18 | -18 | -4 | 18 |
|---|
| Amortization | - | - | - | - | - | 130 | 127 | 133 |
|---|
| Loss (gain) on sale of capital assets | 0 | -2 | -2 | 2 | 1 | 0 | 4 | -1 |
|---|
| Accretion of convertible debt discount | - | - | - | - | - | - | 14 | 11 |
|---|
| Inventory valuation write down | 0 | - | - | - | 67 | 55 | - | - |
|---|
| Asset Impairment Charges | - | 112 | 61 | - | 378 | 934 | - | 2,096 |
|---|
| Other than temporary change in fair value of convertible notes receivable | - | - | - | - | - | 246 | 43 | 22 |
|---|
| Other non-cash items | - | - | - | -3 | 10 | -11 | -14 | 2 |
|---|
| Stock-based compensation | 21 | 32 | 30 | 17 | 36 | 40 | 32 | 24 |
|---|
| Loss on long-term investments & equity investments | -0 | 3 | -2 | -2 | -5 | -2 | -5 | -6 |
|---|
| (Gain) loss on derivative instruments | - | - | - | - | 228 | -31 | -21 | 2 |
|---|
| Change in fair value of contingent consideration | - | -47 | - | - | -45 | 1 | -16 | - |
|---|
| Accounts receivable | 17 | 15 | -6 | - | - | -4 | 7 | 18 |
|---|
| Prepaids and other current assets | 3 | 46 | 5 | - | - | -3 | -13 | 8 |
|---|
| Inventory | 9 | 103 | 30 | - | - | 13 | 16 | 14 |
|---|
| Accounts payable and accrued liabilities | - | - | - | 15 | -45 | 20 | 0 | -23 |
|---|
| Net cash provided by (used in) operating activities | -46 | -258 | -129 | -45 | -177 | 8 | -31 | -95 |
|---|
| Investment in capital and intangible assets | - | - | - | 39 | 34 | 21 | 29 | 33 |
|---|
| Proceeds from disposal of capital and intangible assets | - | - | - | 7 | 12 | 4 | 9 | 7 |
|---|
| Disposal (purchase) of marketable securities, net | - | - | - | - | - | - | -210 | 3 |
|---|
| Business acquisitions, net of cash acquired | - | 164 | - | -67 | -0 | 27 | 61 | 18 |
|---|
| Net cash provided by (used in) investing activities | -99 | -253 | -42 | 46 | -22 | -285 | 128 | -47 |
|---|
| Share capital issued, net of cash issuance costs | - | - | 85 | 103 | 263 | 130 | 9 | 161 |
|---|
| Shares effectively repurchased for employee withholding tax | - | - | - | - | - | 1 | - | - |
|---|
| Proceeds from long-term debt | - | - | - | - | - | - | 33 | 3 |
|---|
| Repayment of long-term debt | - | - | - | - | - | - | 22 | 16 |
|---|
| Proceeds from convertible debt | 460 | - | - | - | - | - | 22 | - |
|---|
| Repayment of convertible debt | - | - | - | - | 88 | 187 | 107 | 0 |
|---|
| Repayment of lease liabilities | - | - | - | 1 | 5 | 1 | 3 | 3 |
|---|
| Net increase (decrease) in bank indebtedness | - | - | - | - | - | 5 | -5 | -11 |
|---|
| Dividend paid to NCI | - | - | - | - | 7 | - | - | 2 |
|---|
| Net cash provided by (used in) financing activities | 631 | 115 | 265 | 124 | 128 | 70 | -75 | 134 |
|---|
| Effect of foreign exchange on cash and cash equivalents | -1 | 6 | -1 | 2 | -2 | -2 | -1 | 1 |
|---|
| Net decrease in cash and cash equivalents | 485 | -390 | 93 | 128 | -73 | -209 | 22 | -7 |
|---|